CERTAIN INFORMATION IDENTIFIED WITH THE MARK “(***)”, HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE SUCH INFORMATION IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE THAT THE COMPANY TREATS AS PRIVATE OR CONFIDENTIAL. Arbeitsvertrag / Employment Agreement...Employment Agreement • May 15th, 2023 • SomaLogic, Inc. • Services-commercial physical & biological research
DEUTSCHE FASSUNG ENGLISH VERSION 1. Erlaubnis zur Arbeitnehmerüberlassung 1. Permit for employee leasing 1.1. Der Arbeitgeber ist im Besitz einer befristeten Erlaubnis nach § 1 AÜG (Arbeitnehmerüberlassungsgesetz), die am 15. März 2019 durch die Agentur für Arbeit Nürnberg in Nürnberg wirksam ab ihrer Bekanntgabe am 19. März 2019 für die Dauer von 1 Jahr d.h. bis zum 19. März 2020 erteilt wurde. 1.1. Employer holds the limited permit according to § 1 Employee Leasing Act (“AÜG”) which was granted on 15 March 2019, effectiv e with its announcement on 19 March 2019 effective for a period of 1 year meaning until 19 March 2020 by the Agency of Employment Nurnberg in Nurnberg. Die Erlaubnis wurde zwischenzeitlich bis zum 19. März 2023 verlängert. Die Erlaubnis und die Verlängerungen sind diesem Vertrag als Anlage 1 in Kopie beigefügt. The permit has meanwhile been extended until 19 March 2023. A copy of the permit and its extensions are attached hereto as Attachment 1. 1.2. Der Arbeitgeber
CONFIDENTIAL SEPARATION AGREEMENT AND GENERAL RELEASEConfidential Separation Agreement and General Release • May 15th, 2023 • SomaLogic, Inc. • Services-commercial physical & biological research
This Confidential Separation Agreement and General Release (“Agreement”) is entered into between Roy Smythe (“Employee”) and SomaLogic, Inc. (“the Company”), collectively referred to as the “Parties.” Reference is made herein to that certain Key Employee Severance Plan adopted by the Company on October 17, 2022 (the “Plan”), under which Employee is a Tier 1 participant. Capitalized terms used but not defined herein shall have the meaning ascribed to them in the Plan.
